Skip to main content

603139 · 陕西康惠制药股份有限公司 · Debt

34.1800 CNY -0.7600 (-2.18%) At close · Sep 30
Market Cap
3.64B CNY
Shares
106.45M

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Lease liabilities 2026-06-30 CNY 30,842,262 Interim report filed 2026-08-29
Long-term borrowings 2026-06-30 CNY 121,600,000 Interim report filed 2026-08-29
Short-term borrowings 2026-06-30 CNY 138,332,332 Interim report filed 2026-08-29
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.